DelveInsight’s, “Colorectal Cancer Pipeline Insight 2025” report provides comprehensive insights about 195+ companies and ...

Accelerated aging in breast cancer survivors is linked to treatments and tumor characteristics, with implications for ...

Delve into the kinase inhibitors' diverse landscape, from cancer breakthroughs to autoimmune disease innovations.

BPDCN is an aggressive hematologic malignancy with a historically poor prognosisVisualDx is a clinical decision support system used by more than ...

Phase III study evaluating palbociclib, a cyclin-dependent kinase 4/6 inhibitor, in patients with hormone receptor-positive, HER2-normal primary breast cancer ... multicentre study evaluating the role ...

The innovative approach targets human epidermal growth factor receptor 2-positive, estrogen receptor-negative (HER2 ... than normal cells. Greedy cancer cells hijack various cellular functions ...

preventing their normal interactions. A previously underappreciated function of lncRNAs is their processing into smaller, functional RNA species. Emerging evidence indicates that lncRNAs can also ...

Lowers Risk of Heart Disease Soy foods, like edamame, have been shown to reduce the risk of heart disease and improve the function of the heart and blood ... However, numerous studies suggest that ...

Herceptin has since revolutionized treatment outcomes and recurrence rates associated with the disease, which are now comparable with that of HER2-normal breast cancer, and in some cases, even better, ...

Antibody-drug conjugates have had a tremendous impact on breast cancer care and treatment, according to Dr. Charles E. Geyer.

Life has evolved over billions of years, adapting to the changing environment. Similarly, enzymes—proteins that speed up ...

Patients with HER2 gene amplification, normal left ventricular ejection fraction (LVEF), and resistant relapse after first- or second-line paclitaxel/carboplatin chemotherapy received paclitaxel ...